Adherence to a procalcitonin-guided antibiotic treatment protocol in patients with severe sepsis and septic shock.

Autor: Hohn A; Department of Anaesthesiology and Intensive Care Medicine, University Hospital of Cologne, Kerpener Str. 62, 50937, Cologne, Germany. andreas.hohn@uk-koeln.de., Balfer N; Department of Anaesthesiology and Intensive Care Medicine, University Hospital of Cologne, Kerpener Str. 62, 50937, Cologne, Germany., Heising B; Department of Infectiology and Hospital Hygiene, Hospital Düren gem. GmbH, Roonstraße 30, 52351, Düren, Germany., Hertel S; Thermo Fisher Scientific, Thermo Scientific Biomarkers, Neuendorfstr. 25, 16761, Hennigsdorf, Germany., Wiemer JC; Thermo Fisher Scientific, Thermo Scientific Biomarkers, Neuendorfstr. 25, 16761, Hennigsdorf, Germany., Hochreiter M; Department of Anaesthesiology, University Hospital Heidelberg, Im Neuenheimer Feld 110, 69120, Heidelberg, Germany., Schröder S; Department of Anaesthesiology, Surgical Intensive Care, Emergency Medicine and Pain Management, Hospital Düren gem. GmbH, Roonstraße 30, 52351, Düren, Germany.
Jazyk: angličtina
Zdroj: Annals of intensive care [Ann Intensive Care] 2018 Jun 04; Vol. 8 (1), pp. 68. Date of Electronic Publication: 2018 Jun 04.
DOI: 10.1186/s13613-018-0415-5
Abstrakt: Background: In randomised controlled trials, procalcitonin (PCT)-guided antibiotic treatment has been proven to significantly reduce length of antibiotic therapy in intensive care unit (ICU) patients. However, concern was raised on low protocol adherence and high rates of overruling, and thus the value of PCT-guided treatment in real clinical life outside study conditions remains unclear. In this study, adherence to a PCT protocol to guide antibiotic treatment in patients with severe sepsis and septic shock was analysed.
Methods: From 2012 to 2014, surgical ICU patients with severe sepsis or septic shock were retrospectively screened for PCT measurement series appropriate to make treatment decisions on antibiotic therapy. We compared (1) patients with appropriate PCT measurement series to patients without appropriate series; (2) patients who reached the antibiotic stopping advice threshold (PCT < 0.5 ng/mL and/or decrease to 10% of peak level) to patients who did not reach a stopping advice threshold; and (3) patients who were treated adherently to the PCT protocol to non-adherently treated patients. The groups were compared in terms of antibiotic treatment duration, PCT kinetics, and other clinical outcomes.
Results: Of 81 patients with severe sepsis or septic shock, 14 were excluded due to treatment restriction or short course in the ICU. The final analysis was performed on 67 patients. Forty-two patients (62.7%) had appropriate PCT measurement series. In patients with appropriate PCT series, median initial PCT (p = 0.001) and peak PCT levels (p < 0.001) were significantly higher compared to those with non-appropriate series. In 26 patients with appropriate series, PCT levels reached an antibiotic stopping advice. In 8 of 26 patients with stopping advice, antibiotics were discontinued adherently to the PCT protocol (30.8%). Patients with adherently discontinued antibiotics had a shorter antibiotic treatment (7d [IQR 6-9] vs. 12d [IQR 9-16]; p = 0.002). No differences were seen in terms of other clinical outcomes.
Conclusion: In patients with severe sepsis and septic shock, procalcitonin testing was irregular and adherence to a local PCT protocol was low in real clinical life. However, adherently treated patients had a shorter duration of antibiotic treatment without negative clinical outcomes. Procalcitonin peak values and kinetics had a clear impact on the regularity of PCT testing.
Databáze: MEDLINE
Externí odkaz: